Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 26, 2022

Valeant Intl Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for VALEANT INTL, and what generic and branded alternatives to VALEANT INTL drugs are available?

VALEANT INTL has seven approved drugs.

Summary for Valeant Intl

US Patents:	0
Tradenames:	5
Ingredients:	3
NDAs:	7

Drugs and US Patents for Valeant Intl

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Intl	HYTONE	hydrocortisone	LOTION;TOPICAL	080473-004	Nov 30, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Valeant Intl	BENZAMYCIN	benzoyl peroxide; erythromycin	GEL;TOPICAL	050557-001	Oct 26, 1984	AB	RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
Valeant Intl	HYTONE	hydrocortisone	CREAM;TOPICAL	080472-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Valeant Intl	HYTONE	hydrocortisone	LOTION;TOPICAL	080473-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
Valeant Intl	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002		RX	Yes	Yes		See Plans and Pricing				See Plans and Pricing
Valeant Intl	RETIN-A	tretinoin	SOLUTION;TOPICAL	016921-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Valeant Intl

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017579-002	Approved Prior to Jan 1, 1982	4,247,547	See Plans and Pricing
Valeant Intl	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002	5,955,109	See Plans and Pricing
Valeant Intl	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-001	Feb 7, 1997	4,690,825	See Plans and Pricing
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017955-001	Approved Prior to Jan 1, 1982	3,729,568	See Plans and Pricing
Valeant Intl	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002	4,690,825	See Plans and Pricing
Valeant Intl	RETIN-A	tretinoin	SOLUTION;TOPICAL	016921-001	Approved Prior to Jan 1, 1982	3,729,568	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for VALEANT INTL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	0.1%	➤ Subscribe	2010-07-08
➤ Subscribe	Gel	0.04%	➤ Subscribe	2010-12-20

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Medtronic

Baxter

Harvard Business School

Moodys

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.